Lead Generation Strategies Icon

Cambridge Healthtech Institute’s Inaugural

Lead Generation Strategies

Small Molecule Drug Discovery Advances

3 - 4 DECEMBER 2024


There has been an explosion of new tools, technologies and approaches in small molecule drug discovery over the past decade. Targeted protein degradation (TPD) strategies, covalent chemistry, computational applications, DNA-encoded libraries (DEL), and fragment-based ligand discovery (FBLD) have expanded chemical space and/or provided drug leads against ‘difficult’ disease targets such as protein-complexes. Join CHI’s Lead Generation Strategies conference to discuss how to integrate chemical information from various screening strategies and which orthogonal biophysical tools to apply, and when, for hit-to-lead drug discovery steps. This is the first time we bring our popular US-based conference to Europe in order to convene a global contingent of pharma, biotech, and academic scientists focused on discovery chemistry.

For more details on the conference, please contact:

Anjani Shah, PhD

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-247-6252

Email: ashah@healthtech.com


For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com

Register Early and Save
Next-Gen Degraders & Molecular Glues
Protein-Protein Interactions

Learn About Our U.S. Event
Register Early and Save